Both in Pharmaceuticals
BioMarin Pharmaceuticals vs Spyre Therapeutics
Over the past year BMRN returned +7.2% and SYRE returned +308.0%; their daily moves had a correlation of 0.21.
BMRN +7.2% SYRE +308.0%Growth of $1, one year, split-adjusted
| Metric | BMRN | SYRE |
|---|---|---|
| Price | $56.65 | $97.02 |
| Market cap | $10.97B | $9.07B |
| Today | +1.78% | −2.27% |
| 1 month | +0.8% | +21.1% |
| 6 months | +3.8% | +32.9% |
| Year to date | −4.7% | +196.2% |
| 1 year | +7.2% | +308.0% |
| Revenue growth (YoY) | +19.9% | — |
| Gross margin | 79.5% | — |
| Net margin | 4.5% | — |
| P/E (TTM) | 150.3× | — |
| Price / sales | 3.2× | — |
| Net cash | -$3.31B | $1.07B |
| Dividend yield | — | — |
| Volatility (60d) | 26.9% | 59.2% |
| Short % of float | 6.2% | 15.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).